Oversimplifies trends and ignores real-world disruptions. Can’t predict economic downturns, competitor actions and shifts in customer behavior on its own. Ignores randomness; every forecast will have ...
Hernexeos is the first oral targeted therapy for HER2-mutant NSCLC, offering a new treatment option for patients with limited alternatives. The Beamion-LUNG 1 trial showed a 75% objective response ...
Four days ahead of its July 7 PDUFA date, the U.S. FDA granted accelerated approval to Dizal (Jiangsu) Pharmaceutical Co. Ltd.’s sunvozertinib (DZD-9008), branded as Zegfrovy, for treating adults with ...
Community driven content discussing all aspects of software development from DevOps to design patterns. Instance main methods and unnamed classes, coming in Java 21, will forever change how developers ...
Master the art of using Generative Fill on non-static video footage with After Effects. This tutorial covers essential techniques to handle moving subjects, track motion, and apply AI-powered fills ...
Thoracic medical oncologists and early drug development specialists at Memorial Sloan Kettering Cancer Center (MSK) continue to investigate new ways to improve outcomes for this patient population.
PITTSBURGH — Wednesday marked a big day for metastatic breast cancer patients who receive treatment at Allegheny Health Network facilities. A small celebration was held for the official launch of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback